A listing of Allergy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The purpose of this study is to evaluate the effect and safety of amikacin liposome inhalation suspension (ALIS) study treatment on patient-reported symptoms in subjects newly diagnosed with NTM lung infection caused by MAC who have not started standard treatment. This is an experimental clinical research study, and ALIS is …
This study is trying to answer the following questions about treating a pulmonary exacerbation: Do participants have the same improvement in lung function and symptoms if they are treated with one type of antibiotic (called beta-lactams or -lactams) versus taking two different types of antibiotics (tobramycin and -lactams)? Is taking …
This study is for patients who have NCFBE who also have comorbid P aeruginosa infections. This study is testing AP-PA02 as a possible treatment for these infections and consists of 5 phages. The study includes physicals, infectious disease blood tests, ECGs, HRCT, blood and urine safety labs and phage labs …
This phase 2b/3 study will use AV-101 dry powder for oral inhalation in patients with PAH. Procedures include PEs, vital signs, safety labs, right heart caths, echocardiograms, QOL questionnaires, 6MWTs, lung function tests, and PK labs.
The study will investigate the eficacy and safety of belumosudil compared with placebo, administered on top of azithromycin and SOC regimen of immunosuppression in male or female participants at least 1 year after bilateral lung transplant, at least 18 years age and with progressive CLAD despite azithromycin.
The purpose of this study is to provide continued treatment with itacitinib to participants who are currently enrolled in the Parent Study of itacitinib.
The main purpose of this study is to see whether inhaling this combination of drugs in RSP-1502 has an acceptable safety profile and works better compared to inhaling tobramycin alone when treating participants with Cystic Fibrosis and chronic Pseudomonas aeruginosa lung infection. Procedures include spirometry, ECG, sputum collection, and pharmacokinetic …
The objectives of this Phase 1/2 prospective interventional trial are to: 1. Evaluate the safety, tolerability, and immunogenicity of a single dose of 4D-710 delivered via nebulization 2. Identify a recommended phase 2 dose (RP2D) for further evaluation 3. Evaluate 4D-710 target gene transduction/expression in bronchoscopic samples (Dose Exploration) and …
Researchers hope to learn more about BMS 986278. The study treatment will be tested at doses of either 120 mg or 60 mg, compared to placebo. There will be 2 cohorts and up to 1185 subjects participating.
Aim: To conduct a pilot open-label study of semaglutide in lung transplant candidates with obesity. - We will get an estimate of recruitment fraction and retention on study drug. - We will determine preliminary effect estimates of change in weight, percent body fat, skeletal muscle mass, and circulating levels of …